Entasis Therapeutics Holdings Inc. Contracts & Agreements
54 Contracts & Agreements
- Business Finance (25 contracts)
- Business Operations (4)
- Human Resources (23)
- Mergers & Acquisitions (1)
- Uncategorized (1)
- Agreement and Plan of Merger, dated as of May 23, 2022, among the Company, Parent and Merger Sub (Filed With SEC on May 23, 2022)
- Amendment No. 1 to Investor Rights Agreement, dated as of May 23, 2022, by and between the Company and Parent (Filed With SEC on May 23, 2022)
- Second Amended Non-Employee Director Compensation Policy, as amended January 1, 2022 (Filed With SEC on March 3, 2022)
- Amendment to Incentive Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Amendment to Incentive Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Amendment to Nonqualified Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Amendment to Nonqualified Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
- Amendment to Stock Option Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
- Amendment to Restricted Stock Unit Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
- Amended Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
- Amended Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
- Form of Retention Bonus Award Memo (Filed With SEC on March 3, 2022)
- Convertible Promissory Note, dated February 18, 2022 (Filed With SEC on February 18, 2022)
- Form of Warrant Certificate (Filed With SEC on February 18, 2022)
- Securities Purchase Agreement, dated February 17, 2022, by and between the Company and Innoviva (Filed With SEC on February 18, 2022)
- Registration Rights Agreement, dated February 18, 2022 by and between the Company and Innoviva (Filed With SEC on February 18, 2022)
- Sales Agreement, dated August 27, 2021, between Entasis Therapeutics Holdings Inc. and Cantor Fitzgerald & Co (Filed With SEC on August 27, 2021)
- Form of Warrant Certificate (Filed With SEC on May 3, 2021)
- Securities Purchase Agreement, dated May 3, 2021, by and between the Company and Innoviva (Filed With SEC on May 3, 2021)
- Form of Registration Rights Agreement (Filed With SEC on May 3, 2021)
- Form of Restricted Stock Unit Grant Notice (Time-Based) (Filed With SEC on November 6, 2020)
- Form of Restricted Stock Unit Grant Notice (Performance-Based) (Filed With SEC on November 6, 2020)
- Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 6, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on September 1, 2020)
- Securities Purchase Agreement, dated August 27, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
- Registration Rights Agreement, dated September 1, 2020, by and between the Company and the Investors named therein (Filed With SEC on September 1, 2020)
- Amended Non-employee Director Compensation Policy, as amended December 6, 2019 (Filed With SEC on August 6, 2020)
- Special Bonus Award Memorandum, dated May 15, 2020 (Filed With SEC on August 6, 2020)
- First Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 6, 2020)
- Form of Executive Officer Employment Agreement (Filed With SEC on May 7, 2020)
- Employment Agreement between the Company and Eric Kimble, effective September 6, 2019 (Filed With SEC on May 7, 2020)
- Non-employee Director Compensation Policy, as amended June 19, 2019 (Filed With SEC on May 7, 2020)
- Registration Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
- Investor Rights Agreement, dated April 22, 2020, by and between the Company and Innoviva (Filed With SEC on April 22, 2020)
- Form of Warrant Certificate (Filed With SEC on April 13, 2020)
- Form of Registration Rights Agreement (Filed With SEC on April 13, 2020)
- Securities Purchase Agreement, dated April 12, 2020, by and between the Company and Innoviva (Filed With SEC on April 13, 2020)
- Form of Voting Agreement (Filed With SEC on April 13, 2020)
- Form of Investor Rights Agreement (Filed With SEC on April 13, 2020)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2020)
- Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2020)
- Registration Rights Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc. and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
- Common Stock Purchase Agreement, dated as of October 21, 2019, by and between Entasis Therapeutics Holdings Inc and Aspire Capital Fund, LLC (Filed With SEC on October 21, 2019)
- Employment Agreement between the Company and Ruben Tommasi, effective September 25, 2018 (Filed With SEC on March 29, 2019)
- Novation of Contract, dated January 11, 2019, by and between the Global Antibiotic Research and Development Partnership and the Company (Filed With SEC on March 29, 2019)
- 2018 Equity Incentive Plan (Filed With SEC on November 14, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on November 14, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2018)
- Registration Rights Agreement, dated as of September 14, 2018 (Filed With SEC on September 18, 2018)
- Employment Agreement with Manoussos Perros (Filed With SEC on September 18, 2018)
- Employment Agreement with Michael Gutch (Filed With SEC on September 18, 2018)
- Employment Agreement with Robin Isaacs (Filed With SEC on September 18, 2018)
- Form of Indemnification Agreement by and between the Registrant and each of its directors and officers (Filed With SEC on September 18, 2018)
